Someone who is anorexic is much more likely to have a heart attack and far more likely to have cholesterol issues because of that condition. A few other situations dont rule you out automatically, but they do call for extra caution and a real conversation: a history of gallbladder disease, diabetic retinopathy (rapid weight loss can temporarily make it worse), and any history of an eating disorder, which warrants screening before treatment starts

Key Benefits Glycemic Control Stimulates insulin secretion in a glucose-dependent manner Reduces inappropriate glucagon levels Improves insulin sensitivity and beta-cell function Controls both fasting and postprandial glucose Weight Management Reduces appetite and food intake Enhances satiety and reduces cravings Activates thermogenesis through glucagon signaling Supports substantial and sustained fat loss Cardiovascular & Metabolic Health Improves lipid profiles (triglycerides, LDL cholesterol) Potentially reduces cardiovascular risk factors Supports liver fat reduction in metabolic-associated fatty liver disease (MAFLD) Dosage & Administration Formulation: 20mg prefilled disposable injection pen with 3ml cartridge Route: Subcutaneous injection Frequency: Once weekly Recommended Dosage Schedule The 20mg pen allows flexible dosing to meet individual treatment goals in both diabetes and obesity management protocols

[PMID: 2489268] PubMed record related to this compound for laboratory literature review
The most common side effectsnausea, constipation, and reduced appetitetypically decrease during the maintenance phase due to lower doses
time of day is flexible as absorption is not affected by food intake
You can inject anytime that fits your schedule without concern about food interfering with absorption, and your dose remains consistent at $189/mo month-to-month, or from $149/mo on the 6-month planno additional cost if you need to adjust your dose upward